Separation anxiety is one of the most distressing and misunderstood behavioral problems in dogs, affecting an estimated 14-17% of the companion dog population. Evidence-based treatment can dramatically improve welfare.
Separation anxiety causes severe, recurring suffering in affected dogs and enormous stress for their owners. Many dogs spend the majority of their lives alone — separation anxiety transforms this common experience into repeated panic episodes. The condition is frequently mismanaged through punishment (which increases anxiety) or confinement (which often escalates self-injury). Evidence-based treatment involves graduated departure training — teaching dogs that short absences predict return and are safe — combined with pharmacological support for moderate-to-severe cases. Fluoxetine (FDA-approved for canine separation anxiety as Reconcile) and trazodone help reduce anxiety enough to allow behavioral modification to succeed. Video monitoring during training is essential to assess actual behavior, not owner-reported approximations. Without treatment, separation anxiety is progressive — brief left-alone time becomes intolerable.